Disease Areas
Diabetes
Obesity
Cardiovascular Disease (CVD)
Chronic Kidney Disease (CKD)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Neurodegenerative Diseases
Haemophilia
Sickle Cell Disease
Primary Hyperoxaluria
Growth Hormone Disorders
Hormone Replacement Therapy
Congresses
Scientific Publications
IME
Register
Login
My Account
Welcome to Novo Nordisk Science Hub
Are you a healthcare professional?
No
Yes
Congresses
Obesity Medicine Association (OMA 2025)
Congresses
{{structuredDataObject}}
National Harbor
,
USA
23 - 27 April 2025
Obesity Medicine Association (OMA 2025)
Presentation schedule and materials
Thursday, 24 April 2025
17:00
- 19:00
EDT
Publication
Medical costs for patients with 12-month continuous semaglutide 2.4 mg use
Prachi Arora, PhD
1
; Wojciech Michalak, MSc
1
; Zhenxiang Zhao, PhD
1
; Megan Fiasconaro, MS
2
; Yu Hong, MS
2
; Xin Zhao, MS
2
; Bríain Ó Hartaigh, PhD
1
; Sara Alvarez, PharmD, MS
1
MATERIALS AVAILABLE
Poster
Share
Copy link
{{pageUrl}}
Keywords
Obesity